Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
The Fund capitalized on risk contango conditions by rotating towards quality defensive pharmaceutical stocks while maintaining overweight China and Europe positions. Strong Chinese technology performance and defensive positioning protected capital during March tariff volatility. The portfolio is well-positioned for potential US economic weakness from tariff policies while benefiting from attractive valuations in quality businesses.
Full Quick Take
The Fund capitalized on risk contango conditions by rotating towards quality defensive pharmaceutical stocks while maintaining overweight China and Europe positions. Strong Chinese technology performance and defensive positioning protected capital during March tariff volatility. The portfolio is well-positioned for potential US economic weakness from tariff policies while benefiting from attractive valuations in quality businesses.
